‘Chemobrain’: Neuroimmunological Consequences Of Chemotherapy-induced Mucositis And Opioid Palliation In Development Of The Condition
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Approximately 46% of cancer patients receiving chemotherapy will experience cognitive impairment. The development of this condition may be linked to another common gut side-effect of chemotherapy- mucositis. The treatment of mucositis pain by potent painkillers called opioids may also increase the risk of cognitive change. This project will determine the nervous system changes occurring in mucositis to identify targets for drug intervention to prevent development of cognitive decline.
Utilising Functional Magnetic Imaging To Predict Pre-clinical Parkinson�s Disease In Patients With Idiopathic Rapid Eye Movement Sleep Behaviour Disorder
Funder
National Health and Medical Research Council
Funding Amount
$83,712.00
Summary
In an ageing Australian population a rise in the number of people with neurodegenerative conditions, such as Parkinson's Disease (PD) is inevitable. The ability to accurately identify those people who are destined to develop such diseases, might offer a mechanism by which such progression could be aborted. This project will seek to identify a reliable method whereby cases of PD could be detected several years before they can currently be diagnosed.